Health Economics
-
Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England
This article has 9 authors:Reviewed by ScreenIT
-
Implementation and economic effects of local non-pharmaceutical interventions
This article has 2 authors:Reviewed by ScreenIT
-
One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19
This article has 13 authors:Reviewed by ScreenIT
-
Health and Economic Consequences of Universal Paid Sick Leave Policies During the COVID-19 Pandemic
This article has 5 authors:Reviewed by ScreenIT
-
Should rapid antigen tests be government funded in Australia? An economic evaluation
This article has 3 authors:Reviewed by ScreenIT
-
COVID-19-associated hospitalizations among children less than 12 years of age in the United States
This article has 10 authors:Reviewed by ScreenIT
-
Financial Burden and Catastrophic Health Expenditure Associated with COVID-19 Hospitalizations in Kerala, South India
This article has 6 authors:Reviewed by ScreenIT
-
TREATMENT COSTS FOR COVID-19 PATIENTS IN A TERTIARY HOSPITAL FROM SERBIA
This article has 14 authors:Reviewed by ScreenIT
-
Comparing health care use after hospital visit for SARS-CoV-2, respiratory syncytial virus, and other respiratory tract infections in children
This article has 5 authors:Reviewed by ScreenIT
-
The primacy of meeting public university students’ essential needs in the wake of COVID-19: An overdue higher education priority
This article has 6 authors:Reviewed by ScreenIT